List of bibliographic references indexed by compounds
Number of relevant bibliographic references: 68.
[0-20] [
0 - 20][
0 - 50][
20-40]
Ident. | Authors (with country if any) | Title |
---|
000184 (2020) |
Joseph Thomas Ortega [États-Unis] ; Maria Luisa Serrano [Venezuela] ; Flor Helene Pujol [Venezuela] ; Hector Rafael Rangel [Venezuela] | Unrevealing sequence and structural features of novel coronavirus using in silico approaches: The main protease as molecular target |
000232 (2020) |
Jrhau Lung [Taïwan] ; Yu-Shih Lin [Taïwan] ; Yao-Hsu Yang [Taïwan] ; Yu-Lun Chou [Taïwan] ; Li-Hsin Shu [Taïwan] ; Yu-Ching Cheng [Taïwan] ; Hung Te Liu [Taïwan] ; Ching-Yuan Wu [Taïwan] | The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase. |
000421 (2020) |
Anh-Tien Ton [Canada] ; Francesco Gentile [Canada] ; Michael Hsing [Canada] ; Fuqiang Ban [Canada] ; Artem Cherkasov [Canada] | Rapid Identification of Potential Inhibitors of SARS-CoV-2 Main Protease by Deep Docking of 1.3 Billion Compounds. |
000490 (2020) |
Francesco Di Pierro [Oman] ; Alexander Bertuccioli [Italie] ; Ilaria Cavecchia [Italie] | Possible therapeutic role of a highly standardized mixture of active compounds derived from cultured Lentinula edodes mycelia (AHCC) in patients infected with 2019 novel coronavirus. |
000661 (2020) |
Deng-Hai Zhang [République populaire de Chine] ; Kun-Lun Wu [République populaire de Chine] ; Xue Zhang [République populaire de Chine] ; Sheng-Qiong Deng [République populaire de Chine] ; Bin Peng [République populaire de Chine] | In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. |
000825 (2020) |
Hongzhou Lu [République populaire de Chine] | Drug treatment options for the 2019-new coronavirus (2019-nCoV). |
000979 (2020) |
Miguel Angel Martinez [Espagne] | Compounds with therapeutic potential against novel respiratory 2019 coronavirus. |
000B50 (2020) |
Ennio Giulio Favalli [Italie] ; Francesca Ingegnoli [Italie] ; Orazio De Lucia [Italie] ; Gilberto Cincinelli [Italie] ; Rolando Cimaz [Italie] ; Roberto Caporali [Italie] | COVID-19 infection and rheumatoid arthritis: Faraway, so close! |
000D16 (2019) |
A. Karaküçük- Yido An [Turquie] ; B. Ayd Nöz [Turquie] ; T. Ta K N-Tok [Turquie] ; E. E. Oruç-Emre [Turquie] ; J. Balzarini [Belgique] | Synthesis, Biological Evaluation and Ligand Based Pharmacophore Modeling of New Aromatic Thiosemicarbazones as Potential Anticancer Agents |
000D17 (2019) |
Mohammed Albratty [Arabie saoudite] ; Karam Ahmed El-Sharkawy [Arabie saoudite] ; Hassan Ahmed Alhazmi [Arabie saoudite] | Synthesis and evaluation of some new 1,3,4-oxadiazoles bearing thiophene, thiazole, coumarin, pyridine and pyridazine derivatives as antiviral agents. |
000D32 (2019) |
Belén Martínez-Gualda [Espagne] ; Liang Sun [Belgique] ; Olaia Martí-Marí [Espagne] ; Carmen Mirabelli [Belgique] ; Leen Delang [Belgique] ; Johan Neyts [Belgique] ; Dominique Schols [Belgique] ; María-José Camarasa [Espagne] ; Ana San-Félix [Espagne] | Modifications in the branched arms of a class of dual inhibitors of HIV and EV71 replication expand their antiviral spectrum. |
000D86 (2018) |
N. Sh. Nadaraia [Géorgie (pays)] ; N. N. Barbakadze [Géorgie (pays)] ; M. L. Kakhabrishvili [Géorgie (pays)] ; B. Sylla ; A. Pichette ; U. S. Makhmudov [Ouzbékistan] | Synthesis and Biological Activity of Several Modified 5α-Androstanolone Derivatives |
000E68 (2017) |
Karima Ighilahriz-Boubchir [Algérie] ; Baya Boutemeur-Kheddis ; Cherifa Rabia ; Malika Makhloufi-Chebli [Algérie] ; Maamar Hamdi ; Artur M. S. Silva | Recyclable Keggin Heteropolyacids as an Environmentally Benign Catalyst for the Synthesis of New 2-Benzoylamino-N-phenyl-benzamide Derivatives under Microwave Irradiations at Solvent-Free Conditions and the Evaluation of Biological Activity |
000F35 (2017) |
Ujjini H. Manjunatha ; Sumiti Vinayak [États-Unis] ; Jennifer A. Zambriski [États-Unis] ; Alexander T. Chao ; Tracy Sy [États-Unis] ; Christian G. Noble ; Ghislain M. C. Bonamy ; Ravinder R. Kondreddi ; Bin Zou ; Peter Gedeck ; Carrie F. Brooks [États-Unis] ; Gillian T. Herbert [États-Unis] ; Adam Sateriale [États-Unis] ; Jayesh Tandel [États-Unis] ; Susan Noh [États-Unis] ; Suresh B. Lakshminarayana ; Siau H. Lim ; Laura B. Goodman [États-Unis] ; Christophe Bodenreider ; Gu Feng ; Lijun Zhang [République populaire de Chine] ; Francesca Blasco ; Juergen Wagner ; F. Joel Leong ; Boris Striepen [États-Unis] ; Thierry T. Diagana | A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis |
000F41 (2016) |
Dorota Rygielska-Tokarska [Pologne] ; Graciela Andrei [Belgique] ; Dominique Schols [Belgique] ; Robert Snoeck [Belgique] ; Iwona E. Głowacka [Pologne] | Synthesis, antiviral, cytotoxic and cytostatic evaluation of N1-(phosphonoalkyl)uracil derivatives |
000F42 (2016) |
Vanessa Parmenopoulou [Grèce] ; Stella Manta [Grèce] ; Athina Dimopoulou [Grèce] ; Nikolaos Kollatos [Grèce] ; Dominique Schols [Belgique] ; Dimitri Komiotis [Grèce] | Synthesis of novel N-acyl-β-d-glucopyranosylamines and ureas as potential lead cytostatic agents |
000F43 (2016) |
Iwona E. Głowacka ; Rafał Gulej ; Piotr Grzonkowski ; Graciela Andrei ; Dominique Schols ; Robert Snoeck ; Dorota G. Piotrowska | Synthesis and the Biological Activity of Phosphonylated 1,2,3-Triazolenaphthalimide Conjugates |
000F44 (2016) |
N. Sh. Nadaraia [Géorgie (pays)] ; E. O. Onashvili [Géorgie (pays)] ; M. L. Kakhabrishvili [Géorgie (pays)] ; N. N. Barbakadze [Géorgie (pays)] ; B. Sylla ; A. Pichette | Synthesis and Antiviral Activity of Several N-Containing 5α-STEROIDS |
000F62 (2016) |
Dorota G. Piotrowska ; Graciela Andrei ; Dominique Schols ; Robert Snoeck ; Magdalena Grabkowska-Dru Yc | New Isoxazolidine-Conjugates of Quinazolinones—Synthesis, Antiviral and Cytostatic Activity |
000F88 (2016) |
Sushanto Gouda [Inde] ; Gitishree Das [Corée du Sud] ; Sandeep K. Sen [Inde] ; Han-Seung Shin [Corée du Sud] ; Jayanta Kumar Patra [Corée du Sud] | Endophytes: A Treasure House of Bioactive Compounds of Medicinal Importance |
001019 (2016) |
Abdo A. Elfiky [Égypte, Italie] | Zika viral polymerase inhibition using anti‐HCV drugs both in market and under clinical trials |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i -k "compounds"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AbsEn.i \
-Sk "compounds" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV2
|flux= Main
|étape= Exploration
|type= indexItem
|index= AbsEn.i
|clé= compounds
}}
| This area was generated with Dilib version V0.6.33. Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021 | |